TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Behavioral Treatment of Overactive Bladder in Men
Brief Summary: The primary purpose of this project is to evaluate the effectiveness of behavioral treatment compared to standard drug therapy for symptoms of OAB in male veterans.


Options:
A: Arm Label: Behavioral Training; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral training | Arm Label: Drug Therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxybutynin chloride, extended-release | Intervention Type: BEHAVIORAL; Name: Behavioral training; Assigned to Arm(s): Behavioral Training | Intervention Type: DRUG; Name: Oxybutynin chloride, extended-release; Assigned to Arm(s): Drug Therapy
B: Arm Label: Exercice; Type: OTHER; Interventions: Behavioral: preparation of the delivery | Arm Label: non-exercice; Type: OTHER; Interventions: Behavioral: preparation of the delivery | Intervention Type: BEHAVIORAL; Name: preparation of the delivery; Assigned to Arm(s): Exercice, non-exercice
C: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise Group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Group | Intervention Type: BEHAVIORAL; Name: Exercise Group; Assigned to Arm(s): Exercise Group
D: Arm Label: Lifestyle Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle Intervention | Arm Label: Diabetes Support and Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Diabetes Support and Education | Intervention Type: BEHAVIORAL; Name: Lifestyle Intervention; Assigned to Arm(s): Lifestyle Intervention | Intervention Type: BEHAVIORAL; Name: Diabetes Support and Education; Assigned to Arm(s): Diabetes Support and Education

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Behavioral Treatment of Overactive Bladder in Men
Brief Summary: The primary purpose of this project is to evaluate the effectiveness of behavioral treatment compared to standard drug therapy for symptoms of OAB in male veterans.


Options:
A: Arm Label: Behavioral Training; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral training | Arm Label: Drug Therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxybutynin chloride, extended-release | Intervention Type: BEHAVIORAL; Name: Behavioral training; Assigned to Arm(s): Behavioral Training | Intervention Type: DRUG; Name: Oxybutynin chloride, extended-release; Assigned to Arm(s): Drug Therapy
B: Arm Label: Dutasteride plus tamsulosin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dutasteride plus tamsulosin | Arm Label: Watchful waiting with escalation to tamsulosin; Type: EXPERIMENTAL; Interventions: Drug: tamsulosin | Intervention Type: DRUG; Name: Dutasteride plus tamsulosin; Assigned to Arm(s): Dutasteride plus tamsulosin | Intervention Type: DRUG; Name: tamsulosin; Assigned to Arm(s): Watchful waiting with escalation to tamsulosin
C: Intervention Type: BEHAVIORAL; Name: Self-management; Assigned to Arm(s): N/A
D: Arm Label: Behavioral and Exercise Therapy (M-BET); Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral, Drug: placebo | Arm Label: Drug Therapy w/ Behavioral Placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin (alpha-adrenergic antagonist medication), Behavioral: placebo | Arm Label: Combination Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Behavioral, Drug: tamsulosin (alpha-adrenergic antagonist medication) | Intervention Type: BEHAVIORAL; Name: Behavioral; Assigned to Arm(s): Behavioral and Exercise Therapy (M-BET), Combination Therapy | Intervention Type: DRUG; Name: tamsulosin (alpha-adrenergic antagonist medication); Assigned to Arm(s): Combination Therapy, Drug Therapy w/ Behavioral Placebo | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Behavioral and Exercise Therapy (M-BET) | Intervention Type: BEHAVIORAL; Name: placebo; Assigned to Arm(s): Drug Therapy w/ Behavioral Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Can Change in Physicians' Prescribing Habits Decrease Carriage of Resistant Bacteria in the Community?
Brief Summary: This study aims to implement judicious antibiotic prescription habits to primary care pediatricians using a multifacet educational intervention and assess two main outcomes: 1) Direct outcome - prescription rates of the physicians. 2)Indirect outcome - carriage of antibiotic resistant bacteria by the treated population, specifically nasopharyngeal S. pneumoniae, nasal S. aureus and rectal E.coli.


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Arm Label: HW; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: HW | Arm Label: HWC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: HWC | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: HW; Assigned to Arm(s): HW | Intervention Type: BEHAVIORAL; Name: HWC; Assigned to Arm(s): HWC
B: Arm Label: Wait-list control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: ADHD Collaborative Intervention; Type: EXPERIMENTAL; Interventions: Other: ADHD Collaborative | Intervention Type: OTHER; Name: ADHD Collaborative; Assigned to Arm(s): ADHD Collaborative Intervention
C: Arm Label: Educational intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Workshops and focus group meetings | Arm Label: Control - no intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Workshops and focus group meetings; Assigned to Arm(s): Educational intervention
D: Intervention Type: BEHAVIORAL; Name: Opinion Leaders, Academic Detailing, Reminders, and Feedback; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Can Change in Physicians' Prescribing Habits Decrease Carriage of Resistant Bacteria in the Community?
Brief Summary: This study aims to implement judicious antibiotic prescription habits to primary care pediatricians using a multifacet educational intervention and assess two main outcomes: 1) Direct outcome - prescription rates of the physicians. 2)Indirect outcome - carriage of antibiotic resistant bacteria by the treated population, specifically nasopharyngeal S. pneumoniae, nasal S. aureus and rectal E.coli.


Options:
A: Arm Label: Educational intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Workshops and focus group meetings | Arm Label: Control - no intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Workshops and focus group meetings; Assigned to Arm(s): Educational intervention
B: Arm Label: DECISION+ Program; Type: EXPERIMENTAL; Interventions: Behavioral: Decision+ program (to improve optimal drug prescription for ARI) | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Decision+ program (to improve optimal drug prescription for ARI); Assigned to Arm(s): DECISION+ Program
C: Arm Label: dosing decision support; Type: EXPERIMENTAL; Interventions: Other: weight based dosing decision support | Arm Label: no decision support; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: weight based dosing decision support; Assigned to Arm(s): dosing decision support
D: Intervention Type: DEVICE; Name: Antimicrobial Prescribing Decision Support; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Adaptive Servo Ventilation(Bipap® Auto SV Advanced) and Oxgen Therapy in Chronic Heart Failure Patients Complicated With Central Sleep Apnea
Brief Summary: The aim of this study is to compare the effects of Adaptive Servo Ventilation (Bipap® auto SV Advanced) and oxygen therapy in chronic heart failure patients complicated with central sleep apnea.


Options:
A: Arm Label: Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Europe: AutoSet CS (USA: VPAP Adapt SV) | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Europe: AutoSet CS (USA: VPAP Adapt SV); Assigned to Arm(s): Treatment Group
B: Arm Label: Nocturnal oxygen therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Nocturnal oxygen | Arm Label: Adaptive servo ventilation; Type: ACTIVE_COMPARATOR; Interventions: Device: Adaptive servo ventilation | Intervention Type: DEVICE; Name: Adaptive servo ventilation; Assigned to Arm(s): Adaptive servo ventilation | Intervention Type: DEVICE; Name: Nocturnal oxygen; Assigned to Arm(s): Nocturnal oxygen therapy
C: Arm Label: Bilevel; Type: ACTIVE_COMPARATOR; Interventions: Device: Bilevel therapy (somnovent ST 22, Weinmann, Hamburg, Germany) | Arm Label: Servoventilation; Type: ACTIVE_COMPARATOR; Interventions: Device: servoventilation (Somnovent CR, Weinmann, Hamburg, Germany) | Intervention Type: DEVICE; Name: Bilevel therapy (somnovent ST 22, Weinmann, Hamburg, Germany); Assigned to Arm(s): Bilevel | Intervention Type: DEVICE; Name: servoventilation (Somnovent CR, Weinmann, Hamburg, Germany); Assigned to Arm(s): Servoventilation
D: Arm Label: MV ASV+OMT; Type: EXPERIMENTAL; Interventions: Device: MV ASV, Drug: Optimized Medical Treatment | Arm Label: OMT only; Type: ACTIVE_COMPARATOR; Interventions: Drug: Optimized Medical Treatment | Intervention Type: DEVICE; Name: MV ASV; Assigned to Arm(s): MV ASV+OMT | Intervention Type: DRUG; Name: Optimized Medical Treatment; Assigned to Arm(s): MV ASV+OMT, OMT only

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Adaptive Servo Ventilation(Bipap® Auto SV Advanced) and Oxgen Therapy in Chronic Heart Failure Patients Complicated With Central Sleep Apnea
Brief Summary: The aim of this study is to compare the effects of Adaptive Servo Ventilation (Bipap® auto SV Advanced) and oxygen therapy in chronic heart failure patients complicated with central sleep apnea.


Options:
A: Arm Label: MV ASV+OMT; Type: EXPERIMENTAL; Interventions: Device: MV ASV, Drug: Optimized Medical Treatment | Arm Label: OMT only; Type: ACTIVE_COMPARATOR; Interventions: Drug: Optimized Medical Treatment | Intervention Type: DEVICE; Name: MV ASV; Assigned to Arm(s): MV ASV+OMT | Intervention Type: DRUG; Name: Optimized Medical Treatment; Assigned to Arm(s): MV ASV+OMT, OMT only
B: Arm Label: positive airway pressure; Type: EXPERIMENTAL; Interventions: Device: CPAP | Intervention Type: DEVICE; Name: CPAP; Assigned to Arm(s): positive airway pressure
C: Arm Label: Nocturnal oxygen therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Nocturnal oxygen | Arm Label: Adaptive servo ventilation; Type: ACTIVE_COMPARATOR; Interventions: Device: Adaptive servo ventilation | Intervention Type: DEVICE; Name: Adaptive servo ventilation; Assigned to Arm(s): Adaptive servo ventilation | Intervention Type: DEVICE; Name: Nocturnal oxygen; Assigned to Arm(s): Nocturnal oxygen therapy
D: Arm Label: Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Europe: AutoSet CS (USA: VPAP Adapt SV) | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Europe: AutoSet CS (USA: VPAP Adapt SV); Assigned to Arm(s): Treatment Group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Can Motivational Interviewing be Effective for Smoking Cessation?
Brief Summary: The purpose of this study is to determine, among a sample of general adult smokers, the effectiveness of three different counseling interventions for motivating quit attempts among smokers not yet ready to quit.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Practice Quit Attempt plus nicotine lozenge | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Practice Quit Attempt only | Intervention Type: OTHER; Name: Practice Quit Attempt plus nicotine lozenge; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Practice Quit Attempt only; Assigned to Arm(s): 2
B: Arm Label: Active Contingency Management; Type: EXPERIMENTAL; Interventions: Drug: Bupropion, Drug: Nicotine replacement therapy, Behavioral: Contingency Management | Intervention Type: DRUG; Name: Bupropion; Assigned to Arm(s): Active Contingency Management | Intervention Type: DRUG; Name: Nicotine replacement therapy; Assigned to Arm(s): Active Contingency Management | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): Active Contingency Management
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Varenicline plus Motivational Interviewing counseling | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Varenicline without counseling | Intervention Type: OTHER; Name: Varenicline plus Motivational Interviewing counseling; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Varenicline without counseling; Assigned to Arm(s): 2
D: Arm Label: Brief Advice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief Advice (BA) | Arm Label: Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing (MI) | Arm Label: Health Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Education (HE) | Intervention Type: BEHAVIORAL; Name: Brief Advice (BA); Assigned to Arm(s): Brief Advice | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing (MI); Assigned to Arm(s): Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Health Education (HE); Assigned to Arm(s): Health Education

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Can Motivational Interviewing be Effective for Smoking Cessation?
Brief Summary: The purpose of this study is to determine, among a sample of general adult smokers, the effectiveness of three different counseling interventions for motivating quit attempts among smokers not yet ready to quit.


Options:
A: Arm Label: Standard Care; Type: EXPERIMENTAL; Interventions: Behavioral: Standard Care | Arm Label: Motivational Enhancement; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Enhancement | Intervention Type: BEHAVIORAL; Name: Standard Care; Assigned to Arm(s): Standard Care | Intervention Type: BEHAVIORAL; Name: Motivational Enhancement; Assigned to Arm(s): Motivational Enhancement
B: Arm Label: Motivation Interviewing/CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing/CBT | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: CONcise Tapes Reviewing Obstacles to healthy Living (CONTROL) | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing/CBT; Assigned to Arm(s): Motivation Interviewing/CBT | Intervention Type: OTHER; Name: CONcise Tapes Reviewing Obstacles to healthy Living (CONTROL); Assigned to Arm(s): Control
C: Arm Label: Brief Advice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief Advice (BA) | Arm Label: Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing (MI) | Arm Label: Health Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Education (HE) | Intervention Type: BEHAVIORAL; Name: Brief Advice (BA); Assigned to Arm(s): Brief Advice | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing (MI); Assigned to Arm(s): Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Health Education (HE); Assigned to Arm(s): Health Education
D: Arm Label: 1 Nix Individual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Nix Individual | Arm Label: 2 Fimpa dig fri; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Fimpa dig fri | Intervention Type: BEHAVIORAL; Name: Nix Individual; Assigned to Arm(s): 1 Nix Individual | Intervention Type: BEHAVIORAL; Name: Fimpa dig fri; Assigned to Arm(s): 2 Fimpa dig fri

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Personal Health Care Partner Project, Conversational IT for Better, Safer Pediatric Primary Care
Brief Summary: Interactive telephony technologies offer a potentially highly effective, patient-centered communication modality by guiding parents at home through interactive discussions that can gather information and actively reinforce recommendations and treatments. Interactive telephony systems are particularly well suited for use in vulnerable populations since access to the telephone is nearly universal, and the system does not rely on reading printed text. The investigators propose to develop and evaluate an integrated patient-centered health information system, the Personal Health Partner (PHP). The PHP will use fully automated, interactive, conversations to gather personal health data and counsel parents before scheduled visits, exchange that data with the child's primary care clinician via the electronic health record (EHR), and offer personalized follow-up assessment and counseling after visits. The information technology-based approach to be evaluated in this project will link parents and children outside the clinical setting with their primary care center and will offer comprehensive assessments AND counseling to reinforce and support parental behavior change.


Options:
A: Arm Label: lifestyle counseling tailored; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored counseling | Arm Label: lifestyle counseling motivational; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interview | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Tailored counseling; Assigned to Arm(s): lifestyle counseling tailored | Intervention Type: BEHAVIORAL; Name: Motivational Interview; Assigned to Arm(s): lifestyle counseling motivational
B: Arm Label: Safety Training; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Safety Training | Arm Label: Personal Health Partner and Counseling (PHP+C); Type: EXPERIMENTAL; Interventions: Behavioral: Personal Health Partner and Counseling (PHP+C) | Intervention Type: BEHAVIORAL; Name: Safety Training; Assigned to Arm(s): Safety Training | Intervention Type: BEHAVIORAL; Name: Personal Health Partner and Counseling (PHP+C); Assigned to Arm(s): Personal Health Partner and Counseling (PHP+C)
C: Arm Label: Intervention Condition; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Web-Based Intervention | Arm Label: Control Condition; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Web-Based Intervention; Assigned to Arm(s): Intervention Condition
D: Arm Label: Targeted Feedback Reports; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Targeted Feedback Reports | Arm Label: Targeted Feedback Report; Type: EXPERIMENTAL; Interventions: Behavioral: Targeted Feedback Report | Intervention Type: BEHAVIORAL; Name: Targeted Feedback Reports; Assigned to Arm(s): Targeted Feedback Reports | Intervention Type: BEHAVIORAL; Name: Targeted Feedback Report; Assigned to Arm(s): Targeted Feedback Report

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lipoic Acid for Neuroprotection in Secondary Progressive MS
Brief Summary: The purpose of the study is to determine if lipoic acid can protect the brain and slow disability in secondary progressive multiple sclerosis.


Options:
A: Intervention Type: DRUG; Name: Triomar™ (omega-3 fatty acids); Assigned to Arm(s): N/A
B: Arm Label: Arm 1: lipoic acid; Type: EXPERIMENTAL; Interventions: Drug: lipoic acid | Arm Label: Arm 2: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: lipoic acid; Assigned to Arm(s): Arm 1: lipoic acid | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm 2: placebo
C: Arm Label: Green tea extract; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Capsules with 160 mg Teavigo (at least 94% EGCG) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Capsules with 160 mg Teavigo (at least 94% EGCG); Assigned to Arm(s): Green tea extract | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Interferon beta-1a 44 mcg SC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Interferon beta-1a, Drug: Ocrelizumab-matching placebo | Arm Label: Ocrelizumab; Type: EXPERIMENTAL; Interventions: Drug: Ocrelizumab, Drug: Interferon beta-1a-matching placebo | Intervention Type: DRUG; Name: Interferon beta-1a; Assigned to Arm(s): Interferon beta-1a 44 mcg SC | Intervention Type: DRUG; Name: Ocrelizumab-matching placebo; Assigned to Arm(s): Interferon beta-1a 44 mcg SC | Intervention Type: DRUG; Name: Ocrelizumab; Assigned to Arm(s): Ocrelizumab | Intervention Type: DRUG; Name: Interferon beta-1a-matching placebo; Assigned to Arm(s): Ocrelizumab

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High Flow Nasal Cannula Versus Nasal Intermittent Mandatory Ventilation for Respiratory Distress Syndrome: a Randomized, Controlled, Prospective Study
Brief Summary: The investigators hypothesize that while the extremely low birthweight (ELBW) infants (\<1000 g) may need NIMV for the treatment of RDS, larger infants or the smaller ones post extubation may enjoy the comfort benefits associated with HFNC while getting coparable respiratory support to NIMV.


Options:
A: Intervention Type: DRUG; Name: Caffeine citrate injection; Assigned to Arm(s): N/A
B: Arm Label: NIMV- nasal respiratory support; Type: EXPERIMENTAL; Interventions: Device: NIMV with SLE ventilator vs HFNC via Vapotherm | Arm Label: HFNC- nasal respiratory support with HFNC; Type: EXPERIMENTAL; Interventions: Device: NIMV with SLE ventilator vs HFNC via Vapotherm | Intervention Type: DEVICE; Name: NIMV with SLE ventilator vs HFNC via Vapotherm; Assigned to Arm(s): HFNC- nasal respiratory support with HFNC, NIMV- nasal respiratory support
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Biphasic Infant flow NCPAP | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: CPAP | Intervention Type: PROCEDURE; Name: Biphasic Infant flow NCPAP; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: CPAP; Assigned to Arm(s): 2
D: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Device: NIPPV | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Device: nCPAP | Intervention Type: DEVICE; Name: nCPAP; Assigned to Arm(s): B | Intervention Type: DEVICE; Name: NIPPV; Assigned to Arm(s): A

Answer: B